SPL028

SPL028
Clinical data
Other namesSPL-028; α,α-Dideutero-N,N-dimethyltryptamine; N,N-D2-dimethyltryptamine; D2-DMT; DMT-d2
Routes of
administration		Intravenous injection, intramuscular injection
Drug classSerotonin receptor modulator; Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Identifiers
PubChem CID
ChemSpider
Chemical and physical data
3D model (JSmol)
  • [2H]C([2H])(CC1=CNC2=CC=CC=C21)N(C)C
  • InChI=1S/C12H16N2/c1-14(2)8-7-10-9-13-12-6-4-3-5-11(10)12/h3-6,9,13H,7-8H2,1-2H3/i8D2
  • Key:DMULVCHRPCFFGV-MGVXTIMCSA-N

SPL028, or SPL-028, also known as α,α-dideutero-N,N-dimethyltryptamine (D2-DMT), is a psychedelic drug of the tryptamine family which is under development for the treatment of depressive disorders. It is the analogue of dimethyltryptamine (DMT) in which the α carbon has been dideuterated. SPL028's route of administration is intravenous injection or intramuscular injection.

This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.